Back to search

France· FR:60009573

PARACETAMOL/CODEINE TEVA 500 mg/30 mg, comprimé pelliculé

A medicinal product containing paracétamol + phosphate de codéine hémihydraté, registered in France by TEVA (PAYS-BAS), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPARACETAMOL/CODEINE TEVA 500 mg/30 mg…ATC—REGISTER NO.FR:60009573PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PARACÉTAMOL + PHOSPHATE DE CODÉINE HÉMIHYDRATÉ
Manufacturer
TEVA (PAYS-BAS)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930167298
    plaquettes PVC-Aluminium de 16 comprimés
    EUR 1.72
  • cip13
    3400930167304
    plaquette(s) PVC-Aluminium polytéréphtalate (PET) papier avec fermeture de sécurité enfant de 16 comprimé(s)
    EUR 1.72

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Paracétamol + phosphate de codéine hémihydraté in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paracétamol + phosphate de codéine hémihydraté products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Belgium · Algocod, Dafalgan
  • Cyprus · Parcoten
  • Czechia · Korylan, Talvosilen Forte
  • Germany · Azur Compositum Sc, Paracetamol Al Comp.
  • Denmark · Kodipar, Pinex Comp
  • Estonia · Algocalm, Paracetamol/Codeine Accord
  • Spain · Analgiplus, Cod-Efferalgan
  • Finland · Panacod, Paracetamol/Codeine Accord
  • United Kingdom (Northern Ireland) · Co-Codamol, Co-Codamol Accord-Uk
  • Greece · Lonalgal
  • Hungary · Parcodin, Talvosilen Forte
  • Ireland · Co-Codamol, Co-Tipol
  • Iceland · Parkódín, Parkódín Forte
  • Italy · Co Efferalgan, Codamol
  • Lithuania · Cocodamol, Cocodamol Actavis
  • Luxembourg · Algocod, Dafalgan
  • Latvia · Co-Codamol Actavis, Paracetamol/Codeine Accord
  • Malta · Codipar, Parcoten
  • Netherlands · Paracetamol/Codeïne Eurogenerics, Paracetamol/Codeïnefosfaat Accord
  • Norway · Altermol, Paracetamol / Codeine Phosphate Hemihydrate Accord
  • Poland · Antidol, Efferalgan
  • Portugal · Dol-U-Ron, Dol-U-Ron Forte
  • Romania · Paradoren, Ultracod
  • Sweden · Altermol, Citodon
  • Slovakia · Korylan, Paramax-Cod

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f82d4d2f-b24c-4dc6-bfd8-5418d09bd766
GET /v1/drugs/f82d4d2f-b24c-4dc6-bfd8-5418d09bd766?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60009573",
  "date_amm": "2018-12-05",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "PARACÉTAMOL + PHOSPHATE DE CODÉINE HÉMIHYDRATÉ",
  "statut_amm": "Autorisation active",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about paracétamol + phosphate de codéine hémihydraté.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.